Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Pacer Trendpilot US Large Cap ETF
PTLC
$3.39B
| $248K | ﹤0.01% |
4,720
+94
| +2% | +$5.21K |
|
3852
NEOS S&P 500 High Income ETF
SPYI
$11.4B
| $248K | ﹤0.01% |
5,015
-6,411
| -56% | -$332K |
|
3853
Bakkt Inc
BKKT
$331M
| $248K | ﹤0.01% |
33,637
+9,156
| +37% | +$108K |
|
3854
Korro Bio
KRRO
$193M
| $246K | ﹤0.01% |
21,730
+2,875
| +15% | +$31.7K |
|
|
WW
3855
WW International
WW
$144M
| $245K | ﹤0.01% |
17,829
+581
| +3% | +$13K |
|
3856
Silvercrest Asset Management
SAMG
$78.9M
| $243K | ﹤0.01% |
18,112
-2,262
| -11% | -$33.6K |
|
3857
Hanover Bancorp
HNVR
$193M
| $243K | ﹤0.01% |
11,273
-1
| -0% | -$22 |
|
3858
Alta Equipment Group
ALTG
$234M
| $243K | ﹤0.01% |
45,245
-6,004
| -12% | -$38.1K |
|
3859
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.62B
| $242K | ﹤0.01% |
3,738
-488
| -12% | -$32.4K |
|
3860
Sixth Street Specialty
TSLX
$1.8B
| $241K | ﹤0.01% |
13,139
-4,336
| -25% | -$85.7K |
|
3861
Definitive Healthcare
DH
$67.9M
| $240K | ﹤0.01% |
194,849
-21,365
| -10% | -$37.1K |
|
3862
Outset Medical
OM
$78.9M
| $239K | ﹤0.01% |
62,360
+2,435
| +4% | +$9.98K |
|
3863
Advantage Solutions
ADV
$429M
| $239K | ﹤0.01% |
11,300
+1,302
| +13% | +$25.1K |
|
3864
Lucid Diagnostics
LUCD
$186M
| $237K | ﹤0.01% |
206,306
+3,506
| +2% | +$4.46K |
|
3865
Dimensional US High Profitability ETF
DUHP
$12.8B
| $237K | ﹤0.01% |
+6,443
| New | +$247K |
|
3866
SelectQuote
SLQT
$129M
| $237K | ﹤0.01% |
375,764
-9,140
| -2% | -$9.6K |
|
|
VFL
3867
DELISTED
abrdn National Municipal Income Fund
VFL
| $235K | ﹤0.01% |
+23,623
| New | +$242K |
|
3868
Rackspace Technology
RXT
$1.08B
| $235K | ﹤0.01% |
239,954
+62,768
| +35% | +$76.3K |
|
|
SFBC
3869
Sound Financial Bancorp
SFBC
$119M
| $235K | ﹤0.01% |
5,376
| – | – |
|
3870
Nuvectis Pharma
NVCT
$635M
| $234K | ﹤0.01% |
30,315
-1,320
| -4% | -$11.3K |
|
3871
Vanguard Consumer Staples ETF
VDC
$8.05B
| $234K | ﹤0.01% |
+1,043
| New | +$239K |
|
3872
KULR Technology Group
KULR
$108M
| $233K | ﹤0.01% |
98,234
+1,902
| +2% | +$5.91K |
|
|
QSIG
3873
WisdomTree U.S. Short Term Corporate Bond Fund
QSIG
$53.3M
| $233K | ﹤0.01% |
4,795
+148
| +3% | +$7.24K |
|
3874
Nkarta
NKTX
$164M
| $232K | ﹤0.01% |
110,004
-29
| -0% | -$65 |
|
|
MANE
3875
Veradermics Inc
MANE
$4.62B
| $232K | ﹤0.01% |
+3,668
| New | +$185K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.